The attractions of the Middle East as a location for clinical research include patient diversity, world-class medical facilities, cost advantages and favourable infrastructure. Indeed multinational CROs think the region is about to experience a surge in clinical trials. Yet there are major discrepancies between countries in terms of adherence to regulations and political stability. Faraz Kermani provides a guide to conducting clinical research in the growth markets of the United Arab Emirates, Kuwait, Saudi Arabia, Qatar, Bahrain, Jordan and Egypt. PDF | Not a subscriber? Subscribe
Why the Gulf Co-operation Council?
Expert View: Faraz Kermani, Principal Analyst 
